(MedPage Today) — Diversion a problem in emergency departments nationwide
FDA Drug Approvals Hit 19-Year High
(MedPage Today) — “Full drug pipelines” suggest pace will be maintained
Uncategorized
CLS-TA meets primary, secondary endpoints in phase 2 clinical trial
CLS-TA has met its primary endpoint of achieving a statistically significant mean change in central subfield thickness from baseline in the phase 2 Dogwood trial, according to topline data released by Clearside Biomedical. The Dogwood trial evaluated t…
CMS Eyes ‘Nurture’ as Key to Health Costs
(MedPage Today) — CMS aims to study impact of addressing health-related social, environmental problems
Uncategorized
VIDEO: Surgeon highlights topics presented at CEDARS/ASPENS meeting
MIAMI — Maria C. Scott, MD, gives highlights from the CEDARS/ASPENS meeting.
Allegro Ophthalmics Announces Last Patient Enrolled in DEL MAR Phase 2b Clinical Trial of Luminate® for the Treatment of Diabetic Macular Edema
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–Allegro Ophthalmics, LLC today announced completion of enrollment in its Phase 2b trial that is evaluating the safety and efficacy of Luminate® (ALG-1001) in patients with diabetic macular edema.